Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial

INTRODUCTION: Recent findings from onchocerciasis-endemic foci uphold that increasing ivermectin coverage reduces the epilepsy incidence, and anecdotal evidence suggests seizure frequency reduction in persons with onchocerciasis-associated epilepsy, when treated with ivermectin. We conducted a rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandro, Michel, Siewe Fodjo, Joseph Nelson, Mukendi, Deby, Dusabimana, Alfred, Menon, Sonia, Haesendonckx, Steven, Lokonda, Richard, Nakato, Swabra, Nyisi, Francoise, Abhafule, Germain, Wonya’Rossi, Deogratias, Jakwong, Jean Marie, Suykerbuyk, Patrick, Meganck, Jacques, Hotterbeekx, An, Colebunders, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977765/
https://www.ncbi.nlm.nih.gov/pubmed/31923177
http://dx.doi.org/10.1371/journal.pntd.0007966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977765/
https://www.ncbi.nlm.nih.gov/pubmed/31923177
http://dx.doi.org/10.1371/journal.pntd.0007966

Ejemplares similares